Article
HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity.
Journal of virology - 1 Nov 2017
Anstett Kaitlin, Brenner Bluma, Mesplède Thibault, Wainberg Mark A
Abstract excerpt
Integrase strand transfer inhibitors (INSTIs) are the newest class of antiretrovirals to be approved for the treatment of HIV infection. Canonical resistance to these competitive inhibitors develops through substitutions in the integrase active site that disrupt drug-protein interactions. However, resistance against the newest integrase inhibitor, dolutegravir (DTG), is associated with an R263K substitution at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
